MAIA Biotechnology (MAIA) Cash from Operations (2021 - 2026)
MAIA Biotechnology (MAIA) posted quarterly Cash from Operations of 5311328.0 for Q1 2026, down 26.39% year-over-year from 7215670.26 in Q1 2025, and up 24.35% quarter-over-quarter from 7020471.0 in Q4 2025.
MAIA Biotechnology (MAIA) Cash from Operations (2021 - 2026) Analysis & Trends
MAIA Biotechnology (MAIA) has reported Cash from Operations for 6 consecutive years, with 5311328.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Operations fell 26.39% year-over-year to 5311328.0; the TTM figure through Mar 2026 stood at 19953652.0 (down 22.27% YoY), while the FY2025 annual figure was 18844598.0, down 20.0% from the prior year.
- Cash from Operations improved to 5311328.0 in Q1 2026 per MAIA's latest filing, from 7020471.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 2019420.0 in Q2 2022 and bottomed at 7020471.0 in Q4 2025.
- Historically, Cash from Operations has averaged 3825147.47 across 5 years, with a median of 3586800.0 in 2024.
- Annual changes were most pronounced in 2022 — Cash from Operations slumped 229.38% — and 2023, when it climbed 26.9%.
- MAIA Biotechnology's Cash from Operations stood at 2949714.0 in 2022, then sank by 35.35% to 3992446.0 in 2023, then gained by 2.11% to 3908175.0 in 2024, then plunged by 79.64% to 7020471.0 in 2025, then grew by 24.35% to 5311328.0 in 2026.
- Business Quant data shows MAIA's Cash from Operations at 5311328.0 in Q1 2026, 7020471.0 in Q4 2025, and 3486516.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | MAIA Biotechnology | 84.50 Mn | 56.91 Mn | - | -6.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.75 Mn |
| Jun 30, 2026 | -6.75 Mn |
| Mar 31, 2026 | -5.31 Mn |
| Mar 31, 2026 | -5.31 Mn |
| Dec 31, 2025 | -7.02 Mn |
| Dec 31, 2025 | -7.02 Mn |
| Sep 30, 2025 | -3.49 Mn |
| Sep 30, 2025 | -3.49 Mn |
| Jun 30, 2025 | -4.14 Mn |
| Jun 30, 2025 | -4.14 Mn |
| Mar 31, 2025 | -4.20 Mn |
| Mar 31, 2025 | -4.20 Mn |
| Dec 31, 2024 | -3.91 Mn |
| Dec 31, 2024 | -3.91 Mn |
| Sep 30, 2024 | -3.52 Mn |
| Sep 30, 2024 | -3.52 Mn |
| Jun 30, 2024 | -4.68 Mn |
| Jun 30, 2024 | -4.68 Mn |
| Mar 31, 2024 | -3.59 Mn |
| Mar 31, 2024 | -3.59 Mn |